Tumour-suppressive microRNA-224 inhibits cancer cell migration and invasion via targeting oncogenic TPD52 in prostate cancer.
Goto Y, Nishikawa R, Kojima S, Chiyomaru T, Enokida H, Inoguchi S, Kinoshita T, Fuse M, Sakamoto S, Nakagawa M, Naya Y, Ichikawa T, Seki N.
Goto Y, et al. Among authors: nishikawa r.
FEBS Lett. 2014 May 21;588(10):1973-82. doi: 10.1016/j.febslet.2014.04.020. Epub 2014 Apr 24.
FEBS Lett. 2014.
PMID: 24768995
Free article.